Hence, whether the peripheral effects of amylin that have been described early after the discovery of amylin (e.g., induction of insulin resistance, inhibition of insulin secretion; summarized in [47,48,49]) are truly mediated by the AMY awaits further investigation. The gene discussed is INS; the disease is Insulin resistance.